Allied Market Research

Latest Research Report to Uncover Key Factors of Global Bioimplants Market with Key Players: Abbott Laboratories , Boston Scientific Corporation, Dentsply Sirona and More

Bio-implants Market Expected to Reach $124,154 Million, Globally, by 2023

 

Portland, OR -- (SBWIRE) -- 05/21/2019 -- Geographically, the developed regions such as North America and Europe together garner majority market share, about 70% of the global bio implants market (2013); however, going forward, it is estimated that the Asia Pacific regional market would lead with a sizable market share of about 20% (2020). Key factors attributable to such altered trend are increasing incidence of lifestyle diseases in the Asia-Pacific region coupled with increasing purchasing power among patients.

Bio-implants Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $115.8 billion by 2020, registering a CAGR of 10.3% during the period 2016 - 2022. Cardiovascular bio implants would garner sizable share among other segments, accounting for 30% of total market throughout the forecast period. Additionally, the orthopedic and dental bio implants are forecast to have a promising growth rate from 2014 to 2020.

Many companies aim to develop and market high-tech variants of bio implants. Such augmented supply-side infrastructure is thus expected to contribute to the overall market growth. DENTSPLY International, Wright Medical group, Invibio Biomaterial Solutions, Biomet (Zimmer), Medtronic, Stryker Corporation, Smith & Nephews, DePuy Synthes, Ethicon Inc., and KLS martin are few key players operating in bio implants market.

Download Sample PDF Brochure at: https://www.alliedmarketresearch.com/request-sample/576

High prevalence of disease conditions such as cardiovascular, orthopedic and spinal disorders that are amenable to treatment via bio implants is the prime driver of the bio implants market. For instance, cardiovascular diseases prevalence is expected to exceed ~12 million by 2020. 30% of such cardiovascular patient population are amenable to treatment via bio implants; analogous factors exist in context of orthopedic, spinal and other disorders. Also, development of variants of bio/raw materials that enhance biocompatibility of bio implants (products) is expected to drive the market growth. Advanced technologies such as 3D printing, laser and nanotechnology deployed for manufacturing bio implants also significantly enhance biocompatibility of bio implants; therefore, it is expected to be another key driver for the global bio implants market.

Key Benefits of Bio-implants Market

- An in-depth analysis of the current bio-implants market scenario in order to estimate future market and to provide trend-analysis that would facilitate decision making
- Quantitative analysis of the current market and estimations through 2013-2020 would assist strategy officials to design business strategies intended to capitalize on opportunities in the market
- Identification of key product segments based on current and potential growth prospects to reveal most profitable segments that can be catered to by the market players
- Analysis of business models, SWOT analysis and key strategies adopted by few leading market players to reveal insights on competitive analysis scenario

Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/576